Hepatitis B Trial

Professor Lim Seng Gee, a Senior Consultant in the Division of Gastroenterology and Hepatology, is leading a study to explore new treatment strategies for Hepatitis B, a potentially fatal viral infection that primarily affects the liver and is a leading cause of liver diseases and liver cancer.  

The focus of this trial is to determine whether patients with Hepatitis B, particularly those with a low amount of viral markers, could benefit from discontinuing their oral antiviral treatment. The study's goal is to assess the potential for recovery and sustained remission after halting antiviral medication in these patients. 

This research could have profound implications for Hepatitis B management and treatment protocols worldwide. Interested individuals seeking more information about the study, participation criteria or other details are encouraged to contact us at 6772 4447. 

For further reading and updates about the study, please click on the following links: 

Print 

Online 

Broadcast